Safety and Efficacy of KPI-121 in Subjects With DED
Clinical trial NCT03616899 · COMPLETED
Trial details
- NCT number
- NCT03616899
- Sponsor
- Kala Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2020-02-05
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.